4//SEC Filing
Gall Matthew 4
Accession 0000899243-21-026087
CIK 0001808865other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 8:00 PM ET
Size
5.4 KB
Accession
0000899243-21-026087
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24+24,000→ 24,000 totalExercise: $23.19Exp: 2031-06-24→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 4 years, with 25% vesting on June 24, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 8:00 PM ET
- Size
- 5.4 KB